Sorafenib in Combination with Betulinic Acid Synergistically Induces Cell Cycle Arrest and Inhibits Clonogenic Activity in Pancreatic Ductal Adenocarcinoma Cells

Pancreatic ductal adenocarcinoma (PDAC) is one of the most deadly cancers in the world due to late diagnosis and poor response to available treatments. It is important to identify treatment strategies that will increase the efficacy and reduce the toxicity of the currently used therapeutics. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutkowska, Justyna, Strzadala, Leon, Rapak, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214124/
https://www.ncbi.nlm.nih.gov/pubmed/30347681
http://dx.doi.org/10.3390/ijms19103234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214124/
https://www.ncbi.nlm.nih.gov/pubmed/30347681
http://dx.doi.org/10.3390/ijms19103234

Ejemplares similares